What is the appropriate management of weeping eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Wet (Weeping) Eczema

Weeping eczema indicates secondary bacterial infection and requires concurrent treatment with systemic antibiotics (flucloxacillin as first-line) while continuing topical corticosteroids—do not delay or withhold steroids when infection is present. 1, 2, 3

Immediate Assessment and Recognition

When you encounter weeping or crusting eczema, this signals secondary bacterial infection, most commonly with Staphylococcus aureus. 1, 2 Key clinical features to identify include:

  • Crusting or weeping lesions suggest bacterial superinfection 1
  • Grouped, punched-out erosions or vesiculation indicate possible herpes simplex infection (eczema herpeticum)—this is a medical emergency 1, 2
  • Take bacteriological swabs if the patient fails to respond to initial treatment 1

Core Treatment Algorithm

Step 1: Initiate Systemic Antibiotics

  • Flucloxacillin is the first-line oral antibiotic for treating S. aureus, the most common pathogen in weeping eczema 1, 2, 3
  • Use phenoxymethylpenicillin if β-hemolytic streptococci are isolated 1
  • Erythromycin is appropriate for penicillin allergy or flucloxacillin resistance 1

Step 2: Continue Topical Corticosteroids

This is a critical point where many clinicians make errors: Do not stop topical corticosteroids when infection is present. 2, 3

  • Topical corticosteroids remain the mainstay of treatment even during active infection, provided appropriate systemic antibiotics are given concurrently 1, 2, 3
  • Apply topical corticosteroids no more than twice daily to affected areas 2
  • Use the least potent preparation that controls symptoms 2, 4
  • For mild eczema, 1% hydrocortisone is adequate and does not cause systemic side effects unless used extravagantly 1, 4

Step 3: Aggressive Emollient Therapy

  • Liberal use of emollients is essential for both cleansing and providing a protective barrier 2, 4
  • Apply emollients after bathing to provide a surface lipid film that retards evaporative water loss 1, 2, 4
  • Use dispersible cream as a soap substitute—avoid regular soaps and detergents that strip natural skin lipids 1, 4
  • Regular bathing is beneficial for cleansing and hydrating the skin 1, 2

Step 4: Adjunctive Measures

  • Keep nails short to minimize trauma from scratching 1
  • Avoid irritant clothing such as wool; cotton clothing is preferred 1
  • Avoid extremes of temperature 1

Special Consideration: Eczema Herpeticum

If you observe grouped vesicles, punched-out erosions, or sudden deterioration with fever, suspect eczema herpeticum—this is a medical emergency. 2, 3

  • Initiate oral acyclovir early in the disease course 1, 2
  • In ill, feverish patients, administer acyclovir intravenously 1, 2
  • Send swabs for virological screening and electron microscopy 1

Common Pitfalls to Avoid

  • Never delay or withhold topical corticosteroids when infection is present—they remain the primary treatment when appropriate systemic antibiotics are given 2, 3
  • Do not use topical corticosteroids continuously without breaks—implement "steroid holidays" when possible 2, 4
  • Address patient or parent fears about steroids directly, as steroid phobia leads to undertreatment in 72.5% of patients 4
  • Very potent and potent corticosteroids should be used with caution for limited periods only 1, 2
  • Avoid high-potency steroids on face, neck, and skin folds where atrophy risk is higher 4

When to Refer or Escalate

  • Failure to respond to treatment after appropriate antibiotics and topical therapy 1
  • Suspected eczema herpeticum (immediate referral required) 2, 3
  • Need for systemic therapy or phototherapy 2, 4
  • Failure to respond to moderate potency topical corticosteroids after 4 weeks 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Eczema (Atopic Dermatitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Folliculitis in Eczema Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Topical Corticosteroid Therapy for Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.